F14.982
BillableCocaine use, unspecified with cocaine-induced sleep disorder
Last updated: FY2026 ICD-10-CM (Oct 1, 2025 – Sep 30, 2026) | CMS-HCC V28 (100% phase-in, PY2026)
Is F14.982 an HCC code?
Yes. F14.982 maps to Drug Use Disorder/Substance Use Disorder, Moderate/Severe under the CMS-HCC V28 risk adjustment model (and Drug/Alcohol Dependence under V24).
HCC Category Mapping
RAF weights shown are the community, non-dual, aged base weights from the CMS risk adjustment model file. Actual per-patient RAF contribution depends on member segment, interactions, and the model year used by the payer. V28 is the CMS-HCC model phased in over payment years 2024–2026; V24 remains in use during the transition and for historical data.
MEAT Criteria for F14.982
For F14.982 to count as a valid HCC diagnosis in a given encounter, the provider's documentation must show MEAT: Monitor, Evaluate, Assess, or Treat. A diagnosis from a prior year does not carry forward automatically — it has to be re-documented and supported each calendar year.
- MMonitor: signs, symptoms, disease progression, or lab trending documented in the note
- EEvaluate: test results, medication response, or physical findings reviewed by the provider
- AAssess: explicit mention in the assessment or plan with acknowledgment of status
- TTreat: medication, referral, procedure, therapy, or counseling tied to the diagnosis
Only one of M/E/A/T is required to support the code, but the documentation must be specific enough to show that the provider actually addressed F14.982 during that encounter — not just copy-forwarded from a problem list.
What This Code Means
F14.982 is the ICD-10-CM diagnosis code for cocaine use, unspecified with cocaine-induced sleep disorder. Cocaine use that causes sleep problems such as insomnia, nightmares, or other sleep disturbances. F14.982 sits in the ICD-10-CM chapter for mental, behavioral and neurodevelopmental disorders (f01-f99), within the section covering mental and behavioral disorders due to psychoactive substance use (f10-f19).
Under the CMS-HCC V28 risk adjustment model, F14.982 maps to Drug Use Disorder/Substance Use Disorder, Moderate/Severe (HCC 137) with a community, non-dual, aged base RAF weight of 0.358. Under the older CMS-HCC V24 model, F14.982 maps to Drug/Alcohol Dependence (HCC 55) with a community, non-dual, aged base RAF weight of 0.334. V28 is the CMS-HCC risk adjustment model that reached 100% phase-in for payment year 2026, replacing V24 which was used during the PY2024–PY2025 transition.
Distinguish between sleep problems during intoxication versus withdrawal phases. Because F14.982 maps to a payment HCC, the provider's documentation must satisfy MEAT criteria (Monitor, Evaluate, Assess, or Treat) for the encounter to count toward the patient's Medicare Advantage risk adjustment score. When documentation is ambiguous, coders should issue a provider query rather than assume the highest-specificity variant.
HCC Buddy maintains structured V28 and V24 mapping, RAF weights, and MEAT documentation criteria for F14.982 sourced directly from the CMS-HCC risk adjustment model files and the CMS ICD-10-CM code set.
Coding Tips
- •Distinguish between sleep problems during intoxication versus withdrawal phases
- •Document the specific sleep disturbance if available (insomnia, hypersomnia, etc.)
Clinical Significance
Cocaine use, unspecified with cocaine-induced sleep disorder captures sleep disruption directly caused by cocaine use in a patient whose use pattern is not specified. Cocaine is a potent central nervous system stimulant that profoundly disrupts sleep architecture, causing insomnia during use and rebound hypersomnia during withdrawal. Chronic sleep disruption contributes to cognitive impairment, mood instability, and impaired immune function, compounding the health effects of cocaine use.
Documentation Requirements
- ✓Documentation of cocaine use
- ✓Specific sleep disorder documented (insomnia, hypersomnia, circadian rhythm disruption)
- ✓Causal relationship between cocaine use and the sleep disorder
- ✓Documentation ruling out primary sleep disorders
- ✓Whether sleep disruption occurs during active use, withdrawal, or both
- ✓Impact on daily functioning